Jianwei YUAN
Partner @ Vertex Ventures China
Jianwei YUAN is a angel investor at Vertex Ventures China focused on Biotechnology and Health Care. He is a partner at Vertex Ventures China. He completed his education at Fudan University.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 57%
Last updated:
For AI agents: llms.txt
Industries Jianwei YUAN invests in
Stages Jianwei YUAN invests in
Countries Jianwei YUAN invests in
Investment Focus
Industry
- Biotechnology 6 (86%)
- Health Care 4 (57%)
- Medical 3 (43%)
- Biopharma 3 (43%)
- Product Research 2 (29%)
Stage
- Angel 2 (29%)
- Series B 2 (29%)
- Venture - Series Unknown 2 (29%)
- Series A 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Primelink Bio
|
Primelink Bio is a Biotechnology firm that is working to to develop next generation of drug delivery systems. | $13.9M / Venture - Series Unknown / Nov 25, 2022 | |
Puji Bio
|
Puji Bio is a medical firm that develops molecular diagnostic kits and instruments for tumor diagnosis, birth defect screening, etc. | $15.7M / Angel / Jan 10, 2022 | |
VelaVigo
|
VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals. | $50M / Angel / Nov 15, 2021 | |
China Immunotech
|
China Immunotech is a small molecule innovative drug R&D company developing immune cell therapy technologies and products. Including CAR-T and TCR-T cell therapy with independent intellectual property rights. It was founded in March 2018 by famous immunologists. | $31M / Venture - Series Unknown / Oct 11, 2021 | |
REJOIN Medical
|
REJOIN Medical specializes in sports medicine & minimally invasive orthopedic solutions for global healthcare professionals. | $15.5M / Series B / Aug 02, 2021 | |
Binhui Biotech
|
Wuhan Binhui Biotechnology Co., Ltd. was established in 2010. The company is located in the Optics Valley Bio City of Donghu National Independent Innovation Demonstration Zone. The company is committed to providing innovative products and services for the field of oncology integration (including diagnosis and treatment), and developing products andservices that have independent intellectual property rights and can compete with other manufacturers on the international stage. | $92.9M / Series B / Feb 10, 2021 | |
NeoX Biotech
|
neoX Biotech is a pharmaceutical company engaged in early-stage drug developmentbased on AI and computational biophysical technology. | $30M / Series A / Feb 02, 2021 |
Co-Investors
About Vertex Ventures China
Vertex Ventures China invests in high-growth internet and technology start-ups across mainland China, and provides funding support and value-add services to portfolio companies in their growth stage. Based in Beijing and Shanghai, Vertex Ventures China collaborates with the Vertex network of ventures funds across US, Israel, Southeast Asia, andIndia, and under auspices of Vertex Holdings providing local knowledge with global perspective.
Vertex Ventures China Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Choon Chong TAY
Managing Partner
|
|||
|
Jianwei YUAN
Partner
|
|||
Li Wei
Managing Partner
|
|||
Ren Gang
Executive Director
|
|||
Tianran LIU
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jianwei YUAN invest in?
Jianwei YUAN invests primarily in Biotechnology, Health Care and Medical startups, most often at Angel and Series B stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jianwei YUAN last invest?
The most recent investment recorded for Jianwei YUAN closed in Nov 2022. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
